MENU
APGE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Apogee Therapeutics (APGE) Ownership - Who owns Apogee Therapeutics?
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need... Show more
Profile
Industry
N/A
Address
221 Crescent Street
Phone
+1 650 394-5230
Employees
91
Web
https://www.apogeetherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.14B
P/E Ratio
N/A
Total Cash
520.65M
Projected Growth
N/A
Total Debt
11.83M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
8.96
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
APGE
Capitalization
2.14B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
521M
Total Cash/Share
8.96
Total Debt
11.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
717M
P/B Ratio
2.99
Cash Flow
N/A
Earnings
-3.3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
18.55
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-216.68M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-31.53
Shares Held By Institutions
3.6B
Shares Outstanding - Current
58.1M
Total Liabilities
37.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-19.360
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
221 Crescent Street
Phone
+1 650 394-5230
Employees
91
Web
https://www.apogeetherapeutics.com